News
EVLO
0.0005
NaN%
--
Weekly Report: what happened at EVLO last week (0421-0425)?
Weekly Report · 1d ago
Weekly Report: what happened at EVLO last week (0414-0418)?
Weekly Report · 04/21 09:18
Weekly Report: what happened at EVLO last week (0407-0411)?
Weekly Report · 04/14 09:16
Weekly Report: what happened at EVLO last week (0331-0404)?
Weekly Report · 04/07 09:16
Weekly Report: what happened at EVLO last week (0324-0328)?
Weekly Report · 03/31 09:18
Weekly Report: what happened at EVLO last week (0317-0321)?
Weekly Report · 03/24 09:16
Weekly Report: what happened at EVLO last week (0310-0314)?
Weekly Report · 03/17 09:17
Weekly Report: what happened at EVLO last week (0303-0307)?
Weekly Report · 03/10 09:18
Weekly Report: what happened at EVLO last week (0224-0228)?
Weekly Report · 03/03 09:18
Weekly Report: what happened at EVLO last week (0217-0221)?
Weekly Report · 02/24 09:18
Weekly Report: what happened at EVLO last week (0210-0214)?
Weekly Report · 02/17 09:17
Weekly Report: what happened at EVLO last week (0203-0207)?
Weekly Report · 02/10 09:17
Weekly Report: what happened at EVLO last week (0127-0131)?
Weekly Report · 02/03 09:17
Weekly Report: what happened at EVLO last week (0120-0124)?
Weekly Report · 01/27 09:18
Weekly Report: what happened at EVLO last week (0113-0117)?
Weekly Report · 01/20 09:16
Weekly Report: what happened at EVLO last week (0106-0110)?
Weekly Report · 01/13 09:17
Weekly Report: what happened at EVLO last week (1230-0103)?
Weekly Report · 01/06 09:18
Weekly Report: what happened at EVLO last week (1223-1227)?
Weekly Report · 12/30/2024 09:17
Weekly Report: what happened at EVLO last week (1216-1220)?
Weekly Report · 12/23/2024 09:18
Weekly Report: what happened at EVLO last week (1209-1213)?
Weekly Report · 12/16/2024 09:18
More
Webull provides a variety of real-time EVLO stock news. You can receive the latest news about Evelo Biosciences through multiple platforms. This information may help you make smarter investment decisions.
About EVLO
Evelo Biosciences, Inc. is a clinical-stage biotechnology company. The Company is focused on discovering and developing a class of oral medicines that act on immune cells in the small intestine with systemic effects. Its small intestinal axis (SINTAX) is the network of connections that links the small intestine and the rest of the body. Immune cells and other cells in the small intestine act as sentinels and are constantly sensing the contents of the gut. Depending on what is sensed, these cells relay messages from the gut to the rest of the body that modulate systemic immunity. Its orally delivered product candidates are pharmaceutical compositions of specific single strains of commensal microbes or the extracellular vesicles (EVs) they shed.